Healthcare · Vaccine antigens production

Vaccine antigens production in Iran in 2026

In 2026, Iran did not produce vaccine antigens on an industrial scale (0 million doses), ranking 72nd globally. The country relies entirely on imported substances for vaccine manufacturing, though local filling and finishing capacities are expanding. The Pasteur Institute of Iran and Hayat Daru are conducting R&D, but mass antigen production has not yet begun.

Data for 2026 · unit: million doses
Position

Iran world ranking

#72 / 197

Country position on the scale from last to first place for this indicator.

IR
#72
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Iran — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Iran's rank by Vaccine antigens production?
Iran ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Iran?
Over the available period the indicator changed from 1 to 0 million doses.